Integrative Psychiatry

Latest News

Catch up on the latest CMEs in Psychiatric Times.
6 Months of Continuing Medical Education

March 11th 2023

Catch up on the latest CMEs in Psychiatric Times.

Revisiting the CME articles featured in Psychiatric Times in 2022.
The Year in CMEs

December 30th 2022

The experts weighed in on a wide variety of psychiatric issues for the October 2022 issue of Psychiatric Times.
From the Pages of Psychiatric Times: October 2022

October 30th 2022

From complementary and alternative approaches in the COVID-19 era to mental health’s most toxic myth, here are highlights from the week in Psychiatric Times.
The Week in Review: October 24-28

October 29th 2022

From herbal medicine for psychiatrists to the psychiatric implications of the Parkland School massing shooting, here are highlights from the week in Psychiatric Times.
The Week in Review: October 17-21

October 22nd 2022

Video Interviews
Podcasts
Latest CME Events & Activities

5th Annual International Congress on the Future of Neurology®

09/22/2023-09/23/2023

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day Two

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day Three

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day One

View More

Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice

View More

Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

10/13/2023

View More

2023 Annual Psychiatric Times™ World CME Conference

10/19/2023 - 10/21/2023

View More

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

View More

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

View More

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

View More

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

View More

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

View More

Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?

View More

2022 4th Annual International Congress on the Future of Neurology

View More

Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals

View More

Clinical Consultations™: Integrating Modern Antipsychotic Medications into the Management of Patients with Schizophrenia

View More

Collaborating Across the Continuum™ : Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy

View More

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Expert Illustrations & Commentaries™: A Family Physicians’ Guide to Migraine Treatment – Emerging Therapies and Evolving Paradigms

View More

PER® Postgame™: MS Meeting Updates – Integrating the Latest Data to Optimize Care in the COVID-19 Era

View More

Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?

View More

Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?

View More

Expert Illustrations & Commentaries™: Visualizing the Role of Antipsychotics in the Management of Schizophrenia: What is the Role of TAAR1?

View More

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

FAQs in MS: Exploring Provocative Questions From MS Meeting Updates

View More

BURST CME™: Taking ALS Management to the Next Level

View More

More News

© 2023 MJH Life Sciences

All rights reserved.